UTM:Healthcare Enhances Remote Patient Monitoring System Connectivity

Mobile health technology company UTM:Healthcare today announced that it has enhanced the connectivity of its remote patient monitoring (RPM) solution through the use of new biometric devices that have greater data transmission capabilities.

Utm:healthcare Enhances Remote Patient Monitoring System Connectivity

UTM:Healthcare has advanced its UTM:RPM solution to make it compatible with cellular-enabled blood pressure monitors, blood glucose meters and pulse oximetry devices. The technology is ideal for monitoring the health of patients who don’t use or can’t afford a smartphone, or may have difficulty pairing biometric devices with their mobile phones.

“With this innovation we are making it easier for even more of the patient population to use remote monitoring technology so that they can continue to maintain their health at home while staying in regular contact with their medical team,” said Seth Lachterman, a partner and co-founder of UTM:Healthcare and its parent company, YouThisMe.

The UTM:RPM solution helps clinicians in various health care settings to remotely monitor their patients’ common chronic conditions, including congestive heart failure, COPD, diabetes and pneumonia. With cellular-enabled biometric devices, patients can take readings of health data at home and transmit directly to the UTM:RPM system, with or without the assistance of the RPM app.

“We look forward to collaborating with health care providers to implement telemedicine tools to improve health outcomes for patients,” Lachterman said.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”